Current Deferiprone market momentum reflects rising transfusion-related iron overload cases, broader regulatory approvals, ...

Vertex Pharmaceuticals Incorporated today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ...